REGENXBIO Inc. SEC filings RGNX
REGENXBIO Inc. has 805 filings in SEC EDGAR's recent list, going back to Nov 7, 2013. Its latest annual report, Form ARS, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 17, 2026 | — |
| FWP | Free writing prospectus | Jul 17, 2026 | — |
| 424B5 | Prospectus supplement | Jul 16, 2026 | — |
| 424B5 | Prospectus supplement | Feb 12, 2026 | — |
| S-3 | Shelf registration | Nov 26, 2025 | — |
| 424B3 | Prospectus | Jun 25, 2025 | — |
| S-3 | Shelf registration | Jun 13, 2025 | — |
| S-8 | Employee stock plan registration | Jun 13, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| POS AM | Filing | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | Dec 9, 2024 | — |
| 424B5 | Prospectus supplement | Mar 8, 2024 | — |
| FWP | Free writing prospectus | Mar 7, 2024 | — |
| 424B5 | Prospectus supplement | Mar 6, 2024 | — |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| 424B5 | Prospectus supplement | Sep 1, 2023 | — |
| S-3ASR | Automatic shelf registration | Aug 4, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| S-3ASR | Automatic shelf registration | Dec 30, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Jan 8, 2021 | — |
| 424B5 | Prospectus supplement | Jan 6, 2021 | — |
| S-8 | Employee stock plan registration | Feb 26, 2020 | — |
| S-8 | Employee stock plan registration | Feb 27, 2019 | — |
| 424B5 | Prospectus supplement | Aug 10, 2018 | — |
| 424B5 | Prospectus supplement | Aug 8, 2018 | — |
| S-3ASR | Automatic shelf registration | Aug 8, 2018 | — |
| S-3 | Shelf registration | Aug 8, 2018 | — |
| S-8 | Employee stock plan registration | Mar 6, 2018 | — |
| 424B5 | Prospectus supplement | Mar 23, 2017 | — |
| 424B5 | Prospectus supplement | Mar 21, 2017 | — |
| S-8 | Employee stock plan registration | Mar 7, 2017 | — |
| S-3/A | Filing | Dec 29, 2016 | — |
| S-3 | Shelf registration | Dec 16, 2016 | — |
| S-8 | Employee stock plan registration | Mar 3, 2016 | — |
| 424B4 | Prospectus | Sep 17, 2015 | — |
| S-8 | Employee stock plan registration | Sep 17, 2015 | — |
| S-1MEF | Filing | Sep 16, 2015 | — |
| S-1/A | Amended registration statement | Sep 16, 2015 | — |
| S-1/A | Amended registration statement | Sep 15, 2015 | — |
| S-1/A | Amended registration statement | Sep 8, 2015 | — |
| S-1 | Registration statement | Aug 17, 2015 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RGNX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Rockville, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1590877
- Former names
- ReGenX Biosciences, LLC (until Nov 7, 2013)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.